NMT (Boston) is closing its doors after failing to meet endpoints in its CLOSURE I pivotal study evaluating its Starflex patent foramen ovale (PFO) closure device. Wednesday's news comes as the company has struggled in recent months to raise additional funds to support its program. (Medical Device Daily) Read More
